Cited by 60Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The Clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients

Ikeda, Masaki, Sharma, Vikram, Mark Sumi, S., Rogaeva, Ekaterina A., Poorkaj, Parvoneh, Sherrington, Robin, Nee, Linda, Tsuda, Takehide +10 more·1996·Annals of Neurology

Abstract

We report the clinical and neuropathologic phenotypes associated with two different missense mutations in the presenilin 1 (PS-1) gene in Japanese patients with early-onset familial Alzheimer's disease (FAD). In the AM/JPN1 pedigree a missense mutation (C-->T) was found at nucleotide 1102, which is predicted to cause an alanine-to-valine missense substitution at codon 260. In this family, the disease had a mean age of onset of 40.3 years and an indolent course (range, 8-19 years). Neuropathologic studies in 3 members of this pedigree showed widespread senile plaques, neurofibrillary tangles, and neuronal loss, as well as abundant perivascular subpial amyloid deposits in the Virchow-Robin spaces and the presence of Pick-like intraneuronal inclusions in the dentate gyrus. In the second pedigree, transmitting a C-->T nucleotide substitution at position 1027, leading to the missense mutation of alanine to valine at codon 285, the disease had a later onset (mean, 51 years) but a more rapid course. Comparison of the disease phenotypes associated with other missense mutations in exon 9 of PS-1 reveals no clinical or pathological phenotype, which uniquely distinguishes Alzheimer's disease associated with PS-1 mutations from other forms of early-onset FAD, implying that direct mutation screening is required to identify these cases.

Integrity signals

Registry

Crossref · 10.1002/ana.410400614

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human PSEN1 mutation carriers have notable BBB breakdown and cerebrovascular dysfunction including cerebellar amyloid angiopathy and CAA, disrupted meningeal, subpial, and cortical arterioles, degeneration of pericytes and SMCs, cerebral perivascular amyloid deposits, and diminished FDG transport across the BBB in an early asymptomatic stage.

    “Human PSEN1 mutation carriers have notable BBB breakdown and cerebrovascular dysfunction including cerebellar amyloid angiopathy and CAA (143, 183, 274, 280, 354, 389, 440, 500, 544, 573, 639, 668); disrupted meningeal, subpial, and cortical arterioles (274, 389, 440); degeneration of pericytes and SMCs (573); cerebral perivascular amyloid deposits (25, 274, 289, 354, 573, 668); and diminished FDG”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [274]

Cited by

Sorted by citations

Authors
Ikeda, M., Sharma, V., Mark Sumi, S., Rogaeva, E. A., Poorkaj, P., Sherrington, R., Nee, L., Tsuda, T., Oda, N., Watanabe, M., Aoki, M., Shoji, M., Abe, K., Itoymia, Y., Hirai, S., Schellenberg, G. D., Bird, T. D., & George‐Hyslop, P. H. S.
Affiliations
  • Gunma University (JP)
  • University of Washington (US)
  • University of Toronto (CA)
  • National Institutes of Health (US)
  • Tohoku University (JP)
Corresponding author
Ikeda, Masaki
Venue
Annals of Neurology
Publisher
Wiley
Published
1996-12
Volume
40
Issue
6
Pages
912-917
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1975673464
Cited by
60
References
0
Citations by year
2025: 2 · 2023: 2 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 3
FWCI
1.83
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (AG0513C, R01AG011762, R01 AG 11762)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
presenilin 1, PS1 mutations, missense mutations, early-onset familial Alzheimer's disease, clinical phenotype, neuropathology, amyloid plaques, neurofibrillary tangles, amyloid deposits, dentate gyrus, age of onset, mutation detection, Japanese patients
MeSH terms
Adult, Alzheimer Disease, Base Sequence, Brain, Female, Hippocampus, Humans, Male, Membrane Proteins, Middle Aged, Molecular Sequence Data, Mutation, Pedigree, Phenotype, Neurofibrillary Tangles, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review